Ongoing NIFA Projects

 

 

Accelerating implementation of HLB-tolerant hybrids as new commercial cultivars for fresh and processed citrus
Dr. Jinhe Bai, USDA-ARS, Fort Pierce, FL. Updated 2/1/2023.

Development of antimicrobial peptides from citrus to kill the CLas bacterium causing HLB
Dr. Ed Stover, USDA-ARS, Fort Pierce, FL. Updated 2/1/2023.

Developing novel biological delivery methods for therapeutic agents and other biomolecules to enhance production of citrus
Dr. Robert Shatters, USDA Horticultural Research Laboratory, Fort Pierce, FL. Updated 2/1/2023.

SP HLB-resistant rootstock candidates for the citrus industry: validating and understanding disease resistance
Dr. John Chater, University of Florida. Updated 4/19/23

Advanced testing and commercialization of novel defensin peptides and therapies for HLB control
Dr. Kranthi Mandadi, Texas A&M AgriLife, College Station, Tx. Updated 4/19/23 

CAP: Combining Individual Protective Covers (IPCs) and brassinosteroids to prolong health and improve fruit yield and quality in newly planted trees under HLB
Dr. Fernando Alferez, UF/IFAS SWFREC. Updated 4/19/23

Method for generating optimally attractive scents for Asian Citrus Psyllid (ACP) biocontrol
Dr. Alexander Aksenov, University of Connecticut and University of Florida. Updated 4/19/23

SP: Virus-induced gene silencing (VIGS) using insect-specific viruses to manipulate psyllids as a strategy to help control citrus greening/HLB
Dr. Yen-Wen Kuo, University of California, Davis. Updated 5/24/23

Phloem-Restricted, Independently Mobile RNA Gene Silencing System for Mitigating Citrus Greening (HLB) by Targeting Liberibacter asiaticus and Citrus Gene Expression
Dr. Anne Simon, University of Maryland. Updated 5/24/23

CAP: Combining cultural and genetic approaches for grove success to unravel and enhance resistance/tolerance to Huanglongbing
Dr. Caroline Roper, Universit of California, Riverside. Updated 5/30/23

Endophytes as sources of antimicrobials to control Huanglongbing (HLB)
Dr. Kateel Shetty, Florida International University, Modesto Maidique Campus Miami. Updated 6/6/23

A collaborative approach between academics, growers, and agrochemical industry to discover, develop and commercialize therapies for citrus huanglongbing (HLB)
Dr. Denise Manker, Biologics at Bayer Crop Science. Updated 6/6/23

Developing tolerance to Huanglongbing disease in citrus by using gene editing
Dr. Zhonglin Mou, University of Florida. Updated 7/8/23

Development, evaluation, and delivery of citrus HLB management approaches by targeting its nature as a pathogen-triggered immune disease
Dr. Nian Wang, University of Florida. Updated 7/8/23

Use performance of 300 hybrids in established trials to map Huanglongbing tolerance/resistance genes and release superior new rootstocks

Dr. Danelle Seymour, University of California, Riverside. Updated 7/8/23

A bench to field pipeline for controlling citrus greening disease: A USDA NIFA Project

Drs.Michelle Heck, Robert Shatters, Jr. and Randall Niedz, USDA Agricultural Research Service. Updated 10/1/23